Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

HMG-CoA Reductase Inhibitors and the Risk of Fractures

Article Abstract:

A group of drugs called statins appears to lower the risk of bone fractures. Statins are used to treat high cholesterol levels. In a study of 3,940 people who had a bone fracture and 23,379 who did not, the use of statins reduced the risk of bone fracture by 45%. Animal studies have shown that statins increase bone density.

Author: Jick, Hershel, Meier, Christoph R., Schlienger, Raymond G., Kraenzlin, Marius E., Schlegel, Brigitta
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2000
Bones, Prevention, Fractures (Injuries), Fractures, Anticholesteremic agents

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Use of beta-blockers and risk of fractures

Article Abstract:

A study is conducted to determine whether the use of beta-blockers alone or in combination with thiazides is associated with a decreased risk of fracture in adults. Many elderly patients with hypertension who are at risk of developing osteoporisis may potentially benefit from combined therapy with beta-blockers and thiazides.

Author: Meier, Christoph R., Schlienger, Raymond G., Kraenzlin, Marius E., Jick, Susan S.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2004
United States, Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Beta Blockers, Care and treatment, Dosage and administration, Osteoporosis, Adrenergic beta blockers, Adrenergic beta-antagonists, Thiazides

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Antibiotics and Risk of Subsequent First-time Acute Myocardial Infarction

Article Abstract:

Bacterial infections may be a risk factor for heart attack. Researchers analyzed antibiotic use in the previous three years by 3,315 heart attack patients and 13,139 healthy people of similar age. Heart attack patients were about 30% less likely to have used tetracycline antibiotics and half as likely to have used quinolone antibiotics as the healthy volunteers. These antibiotics are effective against Chlamydia pneumoniae, which is additional evidence that this bacterium may be involved in heart disease. There were no differences between the two groups in the use of erythromycin, sulfonamides, penicillin, or cephalosporins.

Author: Jick, Hershel, Meier, Christoph R., Jick, Susan S., Vasilakis, Catherine, Derby, Laura E.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1999
Antibiotics, Risk factors, Heart attack

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects
Similar abstracts:
  • Abstracts: Relation of race and sex to the use of reperfusion therapy in Medicare beneficiaries with acute myocardial infarction
  • Abstracts: The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. Prognosis after transient monocular blindness associated with carotid-artery stenosis
  • Abstracts: Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes
  • Abstracts: Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. Causes and outcomes of the acute chest syndrome in sickle cell disease
  • Abstracts: Incidence of intrapartum maternal risk factors for identifying neonates at risk for early-onset group B streptococcal sepsis: a prospective study
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.